The National Consortium for Data Science looks forward to hosting Kimberly Robasky, Associate Director of Machine Learning/AI at Arrakis Therapeutics, on August 22 for our next DataBytes event as she discusses AI in Target Identification and Drug Discovery: Transforming the Future of Medicine.

Register Here

Artificial intelligence (AI) is taking a transformative role in target identification and drug discovery. Today, AI algorithms can analyze vast, multi-modal datasets to identify drug targets, accelerate lead compound discovery, and optimize drug design. AI is being used by biotechnology companies around the world to compress timelines and improving clinical trial outcomes. Join us to uncover the data-driven revolution in personalized medicine enabled by AI-driven drug development.